CXCL2 and prostate cancer: Additionally, this meta-analysis revealed that a subset of the eight genes (ATF3, CXCL2, JUNB, and ZFP36) were significantly up-regulated in normal (non-disease) prostate tissue (S16 Table), further supporting their role as high-confidence regulators of NFκB in prostate cancer.